DWTX: Dogwood Therapeutics, Inc. Stock

by  •  • Comments Off on DWTX: Dogwood Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 10.30
Enterprise Value ($M) 85.24
Book Value ($M) 64.28
Book Value / Share 48.25
Price / Book 0.16
NCAV ($M) -13.48
NCAV / Share -10.12
Price / NCAV -0.76

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -2.96
Return on Equity (ROE) -2.59

Liquidity (mrq)
Quick Ratio 5.21
Current Ratio 5.21

Balance Sheet (mrq) ($M)
Current Assets 16.54
Assets 94.31
Liabilities 30.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -12.23
Net Income -12.35

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-15 13D Sealbond Ltd 15.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 192,054 690,274 27.82
2025-03-13 236,590 785,356 30.13
2025-03-12 1,845,403 5,854,019 31.52
2025-03-11 4,443,037 12,607,442 35.24
2025-03-10 3,494,498 10,358,572 33.74

(click for more detail)

Similar Companies
DRRX – DURECT Corporation DRUG – Bright Minds Biosciences Inc.
DTIL – Precision BioSciences, Inc. DYAI – Dyadic International, Inc.
EDSA – Edesa Biotech, Inc.


Financial data and stock pages provided by
Fintel.io